PHVSPharvaris N.V.

$37.04

$37.04

$20.1252 weeks$37.29

The financials

Pharvaris N.V. by the numbers

Pharvaris N.V. income statement, H2 2025 against the same quarter a year earlier
Income statement	H2 2025	Q2 2024	Change
Operating income	−€82M	−€30M	n/a
Net income	−€84M	−€30M	n/a
Diluted EPS	−€1.29	−€0.55	n/a

Biotechnology

Ranks #45 of 145 by Smart Score

Nurix Therapeutics, Inc.

Mineralys Therapeutics, Inc.

SL Science Holding Limited

MBX Biosciences, Inc.

Maravai LifeSciences Holdings, Inc.